MCL-1 has been identified as a BCR/ABL-dependent survival factor in CML (51) and acts as an anti-apoptotic factor in various neoplastic cells, including several leukemia-derived cell lines (52,53). The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.